Safety and effectiveness of microwave ablation (MWA)as a new thermal ablation technique for lungmalignancies (SAMANTHA)
- Conditions
- C78.0C34Secondary malignant neoplasm of lungMalignant neoplasm of bronchus and lung
- Registration Number
- DRKS00007163
- Lead Sponsor
- Otto-von-Guericke-Universität MagdeburgMedizinische Fakultät
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 36
1. Primary lung cancer (NSCLC)
o Functional irresectable
•FEV1 < 30% and/or
•diffusion capacity <30% and/or
•mx. O2-uptake in spiro-ergometry < 15% and/or
•EF<30% in echocardiography
and/or
oRefusal of surgical treatment by patient
and/or
oInterdisciplinary decision for microablative treatment
2. Secondary lung malignancies
oInterdisciplinary decision for microablative treatment
- Age > 18 years
- Tumor size between 5mm and 50mm
- Positive proof of vitality:
oFDG-uptake in FDG-PET-CT (positive biopsy needed in case of doubts in a positive PET finding in interdisciplinary consensus)
and/or
osize increase of target lesion in CT
and/or
opositive biopsy of the target lesion
- Distance between target lesion and heart > 20mm
- Life expectancy <13 month
- Contraindications for a CT-guided intervention
- Contraindications for a microwave ablation
- Abnormal bleeding parameters (PTT < 50%; platelet count < 50x109/L)
- Respiratory insufficiency (pO2 < 60 or pCO2 > 45)
- Myocardial infarction or stroke within 2 month before intervention
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint of the study is the safety of microwave ablation (MWA) of lung malignancies up to 5cm size.
- Secondary Outcome Measures
Name Time Method local control after MWA after 4 months (PET-CT) and 13 months (CT)<br>local control after MWA of lung tumors in direct contact with vessels, measuring 3mm or larger<br>characteristics of CT imaging and PET-CT follow-up after MWA<br>local tumor control in association to COPD